Trastuzumab or Lapatinib Ditosylate in Treating Women With Early Breast Cancer

NCT01104571 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

257

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: trastuzumab
DRUG: lapatinib ditosylate
OTHER: laboratory biomarker analysis
PROCEDURE: adjuvant therapy
PROCEDURE: neoadjuvant therapy
PROCEDURE: therapeutic conventional surgery

Sponsor

Institute of Cancer Research, United Kingdom

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]